Therapeutic Role of Hydroxyurea in Paediatric Hydroxyurea Pertussis: A systematic review
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Hydroxyurea shows promise for reducing white blood cells in critically ill infants with pertussis, potentially avoiding invasive procedures. However, evidence is limited, requiring further research to confirm safety and efficacy.
Area Of Science
- Pediatric Critical Care Medicine
- Pharmacology
- Infectious Diseases
Background
- Pertussis, particularly in infants, can lead to severe complications including high white blood cell counts (leukocytosis).
- Current management for severe leukocytosis in pediatric critical care may involve invasive leukoreductive procedures.
- There is a need for effective and less invasive therapeutic options for managing leukoreduction in pediatric critical pertussis.
Purpose Of The Study
- To systematically review the existing evidence on the use of hydroxyurea for leukoreduction in pediatric critical pertussis.
- To assess the potential efficacy and safety of hydroxyurea as an adjunctive treatment in this patient population.
Main Methods
- Systematic review of published literature, including case reports and case series.
- Analysis of reported outcomes related to leukocyte reduction and patient survival.
- Evaluation of safety monitoring and follow-up data where available.
Main Results
- Hydroxyurea was associated with leukocyte reduction in reported cases of pediatric critical pertussis.
- Short-term survival was observed in patients treated with hydroxyurea.
- The drug may offer a less invasive alternative to traditional leukoreductive procedures, particularly in resource-limited settings.
Conclusions
- Hydroxyurea presents a potentially promising pharmacologic option for leukoreduction in pediatric critical pertussis.
- The current evidence is limited to low-certainty data from uncontrolled studies, necessitating caution.
- Further rigorous, multicenter studies and randomized controlled trials are essential to validate hydroxyurea's efficacy and safety profile.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...